Anatomy Of A Merger: Grit Helps Shire Seal $32B Baxalta Buy

Kirkland & Ellis LLP client Baxalta Inc. was celebrating its second day as a public company after being spun out from Baxter International Inc. when the rare-disease focused biotechnology company was...

Already a subscriber? Click here to view full article